UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)
CUSIP: 90466Y103
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 18,578,488
- Total 13F shares
- 1,194,501
- Share change
- +43,871
- Total reported value
- $992,000
- Price per share
- $0.83
- Number of holders
- 14
- Value change
- +$8,181
- Number of buys
- 7
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 90466Y103?
CUSIP 90466Y103 identifies UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 90466Y103:
Top shareholders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
3.4%
|
640,633
|
$826,000 | — | 31 Mar 2022 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
1.3%
|
247,583
|
$319,000 | — | 31 Mar 2022 | |
| Ayrton Capital LLC |
13F
|
Company |
0.41%
|
76,645
|
$99,000 | — | 31 Mar 2022 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.2%
|
37,462
|
$48,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.2%
|
37,196
|
$48,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
26,109
|
$33,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.13%
|
24,166
|
$31,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.12%
|
22,695
|
$29,000 | — | 31 Mar 2022 | |
| Frontier Wealth Management LLC |
13F
|
Company |
0.1%
|
18,800
|
$20,000 | — | 31 Mar 2022 | |
| TANDEM CAPITAL MANAGEMENT CORP /ADV |
13F
|
Company |
0.08%
|
15,500
|
$17,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
3,841
|
$5,000 | — | 31 Mar 2022 |
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q2 2022
As of 30 Jun 2022,
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,194,501 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, Ayrton Capital LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Frontier Wealth Management LLC, FineMark National Bank & Trust, TANDEM CAPITAL MANAGEMENT CORP /ADV, CITADEL ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
11
Q2 2022 holders
14
Holder diff
3
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.